Reshentha Beeby is Director & 10% Owner at Acer Therapeutics Inc. (ACER). They have made 1 open-market trade across 1 company since 2018, most recently 2018-08-01.
CIK 0001750983
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5.0M since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACER | 1,697,709 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2018-08-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACER | BUY | 2018-08-01 | 2018-08-22 | $18.00 | $5.0M | -4.6% | -6.8% | -34.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.